Your browser doesn't support javascript.
loading
Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial.
Shiffman, Mitchell L; Cheinquer, Hugo; Berg, Christoph P; Berg, Thomas; de Figueiredo-Mendes, Cláudio; Dore, Gregory J; Ferraz, Maria Lúcia; Mendes-Corrêa, Maria Cássia; Lima, Maria Patelli; Parise, Edison R; Rios, Alma Minerva Perez; Reuter, Tania; Sanyal, Arun J; Shafran, Stephen D; Hohmann, Marc; Tatsch, Fernando; Bakalos, George; Zeuzem, Stefan.
Afiliação
  • Shiffman ML; Liver Institute of Virginia, Bon Secours Health System, Richmond and Newport News, 5855 Bremo Road, Suite 509, Richmond, VA, 23226, USA. mitchell_shiffman@bshsi.org.
  • Cheinquer H; Department of Gastroenterology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil. drhugo@terra.com.br.
  • Berg CP; Department of Internal Medicine, Medizinische Universitätsklinik Tübingen, Tübingen, Germany. christoph.berg@med.uni-tuebingen.de.
  • Berg T; Hepatology Section, Department of Gastroenterology and Rheumatology, Universitätsklinikum Leipzig, Leipzig, Germany. thomas.berg@medizin.uni-leipzig.de.
  • de Figueiredo-Mendes C; Hospital Geral, Santa Casa da Misericórdia do Rio de Janeiro, Rio de Janeiro, Brazil. claudiofigueiredomendes@gmail.com.
  • Dore GJ; Kirby Institute, The University of New South Wales and St. Vincent's Hospital, Sydney, NSW, Australia. gdore@kirby.unsw.edu.au.
  • Ferraz ML; Department of Gastroenterology, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil. marialucia.ferraz@uol.com.br.
  • Mendes-Corrêa MC; Infectious Diseases Research Unit, ABC Foundation Medical School, Santo André, Brazil. cassiamc@uol.com.br.
  • Lima MP; Medical Sciences, Pontifícia Universidade Católica de Campinas, São Paulo, Brazil. mariapatelli@uol.com.br.
  • Parise ER; Department of Gastroenterology, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil. drerparise@terra.com.br.
  • Rios AM; Centro de Investigación Farmacéutica Especializada, Guadalajara, JAL, Mexico. draampr@yahoo.com.mx.
  • Reuter T; Centre for Infectious Diseases, Universidade Federal do Espírito Santo, Vitória, Brazil. tania.reuter@gmail.com.
  • Sanyal AJ; Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University School of Medicine, Richmond, VA, USA. asanyal@mcvh-vcu.edu.
  • Shafran SD; Division of Infectious Diseases, University of Alberta, Edmonton, AB, Canada. sshafran@ualberta.ca.
  • Hohmann M; IST GmbH, Mannheim, Germany. marc.hohmann@ISTGmbH.com.
  • Tatsch F; F. Hoffmann-La Roche Ltd, Basel, Switzerland. fernando.tatsch@abbvie.com.
  • Bakalos G; AbbVie, Chicago, IL, USA. fernando.tatsch@abbvie.com.
  • Zeuzem S; F. Hoffmann-La Roche Ltd, Basel, Switzerland. george.bakalos@roche.com.
Hepatol Int ; 8(4): 517-26, 2014 Oct.
Article em En | MEDLINE | ID: mdl-26202757
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Hepatol Int Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Hepatol Int Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos